
Shobha Kantamneni
Examiner (ID: 1732, Phone: (571)272-2930 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627, 1617, 1623 |
| Total Applications | 1212 |
| Issued Applications | 306 |
| Pending Applications | 120 |
| Abandoned Applications | 793 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11224442
[patent_doc_number] => 09452150
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'Jelly composition'
[patent_app_type] => utility
[patent_app_number] => 11/660359
[patent_app_country] => US
[patent_app_date] => 2005-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7513
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 330
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11660359
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/660359 | Jelly composition | Aug 17, 2005 | Issued |
Array
(
[id] => 5727567
[patent_doc_number] => 20060058328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Use of N-aryl diazaspiracyclic compounds in the treatment of addiction'
[patent_app_type] => utility
[patent_app_number] => 11/207102
[patent_app_country] => US
[patent_app_date] => 2005-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23040
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20060058328.pdf
[firstpage_image] =>[orig_patent_app_number] => 11207102
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/207102 | Use of N-aryl diazaspiracyclic compounds in the treatment of addiction | Aug 17, 2005 | Abandoned |
Array
(
[id] => 4693114
[patent_doc_number] => 20080085885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-10
[patent_title] => 'Inhibition Of Voluntary Ethanol Consumption With Non-Peptidyl Melanocortin-4 Receptor Agonists'
[patent_app_type] => utility
[patent_app_number] => 11/660117
[patent_app_country] => US
[patent_app_date] => 2005-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14844
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20080085885.pdf
[firstpage_image] =>[orig_patent_app_number] => 11660117
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/660117 | Inhibition Of Voluntary Ethanol Consumption With Non-Peptidyl Melanocortin-4 Receptor Agonists | Aug 8, 2005 | Abandoned |
Array
(
[id] => 7243667
[patent_doc_number] => 20050271673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Trifunctional reagent for conjugation to a biomolecule'
[patent_app_type] => utility
[patent_app_number] => 11/190955
[patent_app_country] => US
[patent_app_date] => 2005-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4989
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0271/20050271673.pdf
[firstpage_image] =>[orig_patent_app_number] => 11190955
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/190955 | Trifunctional reagent for conjugation to a biomolecule | Jul 27, 2005 | Abandoned |
Array
(
[id] => 5819951
[patent_doc_number] => 20060024264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Antimicrobial copolymers and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/186942
[patent_app_country] => US
[patent_app_date] => 2005-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20311
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024264.pdf
[firstpage_image] =>[orig_patent_app_number] => 11186942
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/186942 | Antimicrobial copolymers and uses thereof | Jul 21, 2005 | Abandoned |
Array
(
[id] => 5769329
[patent_doc_number] => 20060019967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'SARS CoV main protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/185917
[patent_app_country] => US
[patent_app_date] => 2005-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 5697
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019967.pdf
[firstpage_image] =>[orig_patent_app_number] => 11185917
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/185917 | SARS CoV main protease inhibitors | Jul 19, 2005 | Abandoned |
Array
(
[id] => 4840512
[patent_doc_number] => 20080280998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Bifunctional Derivatives of Polyethylene Glycol, Their Preparation and Use'
[patent_app_type] => utility
[patent_app_number] => 11/570926
[patent_app_country] => US
[patent_app_date] => 2005-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5642
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20080280998.pdf
[firstpage_image] =>[orig_patent_app_number] => 11570926
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/570926 | Bifunctional Derivatives of Polyethylene Glycol, Their Preparation and Use | Jun 20, 2005 | Abandoned |
Array
(
[id] => 7691449
[patent_doc_number] => 20070232584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Composition and Method for the Treatment of Tauopathies'
[patent_app_type] => utility
[patent_app_number] => 11/597771
[patent_app_country] => US
[patent_app_date] => 2005-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14363
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20070232584.pdf
[firstpage_image] =>[orig_patent_app_number] => 11597771
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/597771 | Composition and method for the treatment of tauopathies | May 25, 2005 | Issued |
Array
(
[id] => 5769181
[patent_doc_number] => 20060019934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Anti-HIV-1 activity of betulinol derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/131851
[patent_app_country] => US
[patent_app_date] => 2005-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6772
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019934.pdf
[firstpage_image] =>[orig_patent_app_number] => 11131851
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/131851 | Anti-HIV-1 activity of betulinol derivatives | May 17, 2005 | Abandoned |
Array
(
[id] => 5596881
[patent_doc_number] => 20060160799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Transcription factor modulating compounds and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/115024
[patent_app_country] => US
[patent_app_date] => 2005-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 58849
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160799.pdf
[firstpage_image] =>[orig_patent_app_number] => 11115024
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/115024 | Transcription factor modulating compounds and methods of use thereof | Apr 24, 2005 | Abandoned |
Array
(
[id] => 7188395
[patent_doc_number] => 20050192305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'HIV inhibiting pyrimidine derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/111400
[patent_app_country] => US
[patent_app_date] => 2005-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15000
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192305.pdf
[firstpage_image] =>[orig_patent_app_number] => 11111400
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/111400 | HIV inhibiting pyrimidine derivatives | Apr 20, 2005 | Abandoned |
Array
(
[id] => 5259774
[patent_doc_number] => 20070213406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Anti-Inflammatory Analgesic External Aqueus Liquid Preparation'
[patent_app_type] => utility
[patent_app_number] => 11/578152
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2303
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20070213406.pdf
[firstpage_image] =>[orig_patent_app_number] => 11578152
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/578152 | Anti-Inflammatory Analgesic External Aqueus Liquid Preparation | Mar 22, 2005 | Abandoned |
Array
(
[id] => 7051301
[patent_doc_number] => 20050187188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Methods for the treatment of a traumatic central nervous system injury'
[patent_app_type] => utility
[patent_app_number] => 11/085889
[patent_app_country] => US
[patent_app_date] => 2005-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15197
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187188.pdf
[firstpage_image] =>[orig_patent_app_number] => 11085889
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/085889 | Methods for the treatment of a traumatic central nervous system injury | Mar 21, 2005 | Abandoned |
Array
(
[id] => 7040744
[patent_doc_number] => 20050159488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'D-serine transport antagonist for treating psychosis'
[patent_app_type] => utility
[patent_app_number] => 11/080551
[patent_app_country] => US
[patent_app_date] => 2005-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4299
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20050159488.pdf
[firstpage_image] =>[orig_patent_app_number] => 11080551
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/080551 | D-serine transport antagonist for treating psychosis | Mar 15, 2005 | Abandoned |
Array
(
[id] => 5638096
[patent_doc_number] => 20060069070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Treatment of fibrosis using FXR ligands'
[patent_app_type] => utility
[patent_app_number] => 11/081002
[patent_app_country] => US
[patent_app_date] => 2005-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22273
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069070.pdf
[firstpage_image] =>[orig_patent_app_number] => 11081002
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/081002 | Treatment of fibrosis using FXR ligands | Mar 13, 2005 | Issued |
Array
(
[id] => 7045210
[patent_doc_number] => 20050249805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => ' Compositions and methods for treating hepatitis C virus (HCV) infection'
[patent_app_type] => utility
[patent_app_number] => 11/017531
[patent_app_country] => US
[patent_app_date] => 2004-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 22173
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20050249805.pdf
[firstpage_image] =>[orig_patent_app_number] => 11017531
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/017531 | Compositions and methods for treating hepatitis C virus (HCV) infection | Dec 17, 2004 | Abandoned |
Array
(
[id] => 6939711
[patent_doc_number] => 20050113274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Hydrocarbyl aminohydrocarbonoates and aminohydrocarbonol hydrocarbonoates as antimicrobial and antiviral agents'
[patent_app_type] => utility
[patent_app_number] => 10/994591
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4590
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113274.pdf
[firstpage_image] =>[orig_patent_app_number] => 10994591
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/994591 | Hydrocarbyl aminohydrocarbonoates and aminohydrocarbonol hydrocarbonoates as antimicrobial and antiviral agents | Nov 18, 2004 | Abandoned |
| 10/994108 | Polyamine conjugates as selective NMDA inhibitors and anti-cancer drugs | Nov 18, 2004 | Abandoned |
Array
(
[id] => 5711028
[patent_doc_number] => 20060052373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Combination of dopamine agonists and aralkyl and aralkylidene heterocyclic lactams and imides'
[patent_app_type] => utility
[patent_app_number] => 10/991046
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8517
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052373.pdf
[firstpage_image] =>[orig_patent_app_number] => 10991046
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/991046 | Combination of dopamine agonists and aralkyl and aralkylidene heterocyclic lactams and imides | Nov 16, 2004 | Abandoned |
Array
(
[id] => 6991479
[patent_doc_number] => 20050090516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Novel substituted imides'
[patent_app_type] => utility
[patent_app_number] => 10/989945
[patent_app_country] => US
[patent_app_date] => 2004-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8404
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090516.pdf
[firstpage_image] =>[orig_patent_app_number] => 10989945
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/989945 | Substituted imides | Nov 15, 2004 | Issued |